Who: North Carolina State University and the University of North Carolina at Chapel Hill, USA.
What: Daisy-shaped, nanoscale structures that are made predominantly of anti-cancer drugs and are capable of introducing a “cocktail” of multiple drugs into cancer cells. See “Folding graft copolymer with pendant drug segments for co-delivery of anticancer drugs”
Where: More effective anti-cancer drug delivery. Once injected, the nanodaisies float through the bloodstream until they are absorbed by cancer cells.
When: Compliance with international regulatory industrial and healthcare guidelines before commercialization and translational medicine can take over 10 years and the cost of producing a new drug can be upwards of $800 million.
